Healer

JANUARY 17, 2022

People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. Check Out Our CBG Webinar. People who want to enhance the benefits of THC.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Healer

JANUARY 17, 2022

People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. Check Out Our CBG Webinar. People who want to enhance the benefits of THC.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

The Cannigma

APRIL 7, 2022

So you look at these studies on CBD and epilepsy, I mean they’re not taking ten milligrams. It is the concentration. We have a certain few members-only webinars throughout the year and things like that. CP: Interesting. I guess it’s interesting, because it’s not on the package insert of these products.

Terpenes 52

Terpenes Wellness and Beauty Cannabis Extraction 52